The contribution of drug-related deaths to the US disadvantage in mortality
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: The USA ranks last in life expectancy among high-income countries. Since 2000, excess US mortality has been particularly concentrated in the working ages, which are also the ages hardest hit by the increase in drug deaths. This study measures the effect of drug-related mortality on the gap in life expectancy between the USA and other countries. Methods: Data from the Human Mortality Database and the World Health Organization were combined to construct age-standardized mortality rates for 2000–14 in 12 high-income countries and the USA for seven broad causes of death, including drug use. The contribution of each cause to the difference in life expectancy between the USA and the other 12 countries was estimated. Results: In 2014, the increase in drug-related deaths accounted for 10–15% of the US disadvantage in mortality, but with marked differences by age group. For working-age men, the increase in drug-related deaths accounted for up to 38% of the difference. Overall, American mortality is higher than the comparison countries across a wide range of causes. Conclusions: The severity of the drug epidemic appears to be specific to the USA, but it only partly contributes to the American shortfall in mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century
Case, A., & Deaton, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518393112 · Cited by 2,759
Increases in drug and opioid-involved overdose deaths – United States, 2010-2015
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm655051e1 · Cited by 2,194
Opioid crisis: no easy fix to its social and economic determinants
Dasgupta, N., Beletsky, L., & Ciccarone, D. (2018) · American Journal of Public Health · doi:10.2105/ajph.2017.304187 · Cited by 923
Mortality among people who inject drugs: a systematic review and meta-analysis
Mathers, B. M., Degenhardt, L., Bucello, C., Lemon, J., Wiessing, L., & Hickman, M. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.12.108282 · Cited by 476
Avendano, M., & Kawachi, I. (2014) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-032013-182411 · Cited by 195
Data resource profile: the Human Mortality Database (HMD)
Barbieri, M., Wilmoth, J. R., Shkolnikov, V. M., Glei, D., Jasilionis, D., Jdanov, D., Boe, C., Riffe, T., Grigoriev, P., & Winant, C. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv105 · Cited by 168
Cited by
Drug Overdose Deaths in the United States, 1999–2020
Hedegaard, H., Miniño, A., Spencer, M. R., & Warner, M. (2021) · doi:10.15620/cdc:112340 · Cited by 1,283
Life Expectancy and Mortality Rates in the United States, 1959-2017
Woolf, S. H., & Schoomaker, H. (2019) · JAMA · doi:10.1001/jama.2019.16932 · Cited by 930
US life expectancy stalls due to cardiovascular disease, not drug deaths
Mehta, N. K., Abrams, L. R., & Myrskylä, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920391117 · Cited by 240
Progress Stalled? The Uncertain Future of Mortality in High‐Income Countries
Dowd, J. B., Polizzi, A., & Tilstra, A. M. (2025) · Population and Development Review · doi:10.1111/padr.12687 · Cited by 21
Insights into US life expectancy stagnation from birth cohort mortality dynamics
Abrams, L., Bramajo, O., van Raalte, A., Myrskylä, M., & Mehta, N. K. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2519356123 · Cited by 6
Metadata
- Authors
- Barbieri, M.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-12-28
- Volume
- 48
- Issue
- 3
- Pages
- 945-953
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2907421710
- Cited by
- 28
- References
- 6
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.